• Home>
  • Stocks>
  • Syncom Formulations (India) Ltd Share Price
Syncom Formulations (India) Ltd share price logo

Syncom Formulations (India) Ltd Share Price

(SYNCOMF)

Small Cap

Healthcare Sector

₹17.14▲3.6%

as on 04:01PM, 04 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Syncom Formulations (India) Ltd Performance

  • Day's Low

    Day's High

    ₹16.9
    Day's Price Range
    ₹17.8

  • 52 Week's Low

    52 Week's High

    ₹10.95
    52-Week Price Range
    ₹27.9
1 Month Return+ 8.96 %
3 Month Return-12.91 %
1 Year Return+ 26.03 %
Previous Close₹17.78
Open₹17.78
Volume21.70L
Upper Circuit₹21.33
Lower Circuit₹14.22
Market Cap₹1,611.16Cr

Syncom Formulations (India) Ltd Fundamentals

P/E Ratio

33.61

PEG Ratio

197.69

Market Cap

₹1,611.16 Cr

P/B Ratio

3.67

EPS

0.27

Dividend Yield

0

Sector

Pharmaceuticals

ROE

8.71

Mutual Fund Holdings of Syncom Formulations (India) Ltd

Key events for Syncom Formulations (India) Ltd

  • Syncom Formula Reports Strong Financial Growth - 20 Feb, 2025

    Syncom Formula Consolidated reported a 95.78% increase in net sales to Rs 127.53 crore for December 2024. Net profit rose 85.7% to Rs 13.00 crore, with EBITDA up 57.47%. EPS increased to Rs 0.14. The stock closed at Rs 16.97 on February 18, 2025, showing positive returns over the last 6 and 12 months.

  • Syncom Formula Reports Strong Growth in December 2024 - 14 Feb, 2025

    Syncom Formula's standalone net sales for December 2024 reached Rs 127.03 crore, up 100.54% YoY. Net profit rose 99.22% to Rs 12.79 crore, with EBITDA increasing by 65.29%. EPS improved to Rs 0.14. The stock closed at Rs 18.04 on February 12, 2025, reflecting positive returns over the past 6 and 12 months.

Insights on Syncom Formulations (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.10% to 0.13% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 7 quarters, 4.4 Cr → 13.0 Cr (in ₹), with an average increase of 15.6% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 7 quarters, 61.71 Cr → 131.57 Cr (in ₹), with an average increase of 11.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, SYNCOMF stock has moved up by 9.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 135.9% return, outperforming this stock by 82.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 46.3% return, outperforming this stock by 20.3%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 50.57% of holdings in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 49.33% to 49.30% in Dec 2024 quarter

Syncom Formulations (India) Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹65.14Cr (-)₹74.57Cr (↑14.48%)₹86.29Cr (↑15.72%)₹102.31Cr (↑18.57%)₹127.53Cr (↑24.65%)
Net Income₹7.00Cr (-)₹7.40Cr (↑5.71%)₹7.63Cr (↑3.11%)₹11.11Cr (↑45.61%)₹13.00Cr (↑17.01%)
Net Profit Margin10.75% (-)9.92% (↓7.72%)8.84% (↓10.89%)10.86% (↑22.85%)10.19% (↓6.17%)
Value in ₹ crore
Details2021202220232024
Total Assets₹292.03Cr (-)₹308.83Cr (↑5.75%)₹377.62Cr (↑22.27%)₹392.33Cr (↑3.90%)
Total Liabilities₹104.44Cr (-)₹86.60Cr (↓17.08%)₹121.61Cr (↑40.43%)₹105.88Cr (↓12.93%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹5.86Cr (-)-₹2.06Cr (↓135.15%)₹16.33Cr (↓892.72%)₹10.50Cr (↓35.70%)-₹5.94Cr (↓156.57%)

Syncom Formulations (India) Ltd Index Inclusions

BSE Healthcare

₹40,531.58

-3.2 (▲-1339.21%)

BSE Small-Cap

₹45,867.17

-3.43 (▲-1626.94%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

Syncom Formulations (India) Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
50.57%
0.00
Foreign Institutions
0.13%
28.33
Mutual Funds
0%
28.57
Retail Investors
49.3%
-0.06
Others
0%
0.00

Syncom Formulations (India) Ltd Key Indicators

Details20202021202220232024
Return On Equity %10.2417.519.668.398.71
Details20232024
Return On Assets %5.316.45
Details20162017202220232024
Book Value Per Share (₹)1.391.52.522.723.07
Details20162017202220232024
Earning Per Share (₹)0.130.130.230.210.27

Syncom Formulations (India) Ltd Valuation

Syncom Formulations (India) Ltd in the last 5 years

  • Overview

  • Trends

Lowest (3.98x)

March 12, 2020

Today (33.61x)

April 4, 2025

Industry (53.63x)

April 4, 2025

Highest (81.74x)

January 18, 2022

LowHigh

Syncom Formulations (India) Ltd Earnings and Dividends

  • Syncom Formulations (India) Ltd Earnings Results

    Syncom Formulations (India) Ltd’s net profit jumped 85.71% since last year same period to ₹13Cr in the Q3 2024-2025. On a quarterly growth basis, Syncom Formulations (India) Ltd has generated 17.01% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Syncom Formulations (India) Ltd Dividends August,2022

    In the quarter ending June 2022, Syncom Formulations (India) Ltd has declared dividend of ₹0.03 - translating a dividend yield of 0.18%.

    Read More about Dividends

Syncom Formulations (India) Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Syncom Formulations (India) Ltd is currently in a Bearish trading position according to technical analysis indicators.

More on Technical Analysis

Syncom Formulations (India) Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd
NA₹1,611.16 Cr484.12%0.61₹25 Cr₹263 Cr
Parnax Lab Ltd
Parnax Lab Ltd
NA₹124.22 Cr156.57%0.50₹9 Cr₹188 Cr
Auro Laboratories Ltd
Auro Laboratories Ltd
NA₹156.50 Cr116.71%0.69NANA
Kwality Pharmaceuticals Ltd
Kwality Pharmaceuticals Ltd
NA₹859.67 Cr514.52%0.65₹23 Cr₹307 Cr
Kopran Ltd
Kopran Ltd
NA₹891.64 Cr116.79%0.53₹50 Cr₹614 Cr
See all

About Syncom Formulations (India) Ltd

Syncom Formulations India is a public limited company that was established in 1988 and converted to public limited in 1992. It manufactures pharmaceutical formulations, injectibles, ear/eye drops, and herbal products such as Edicare Attom Megacaps Ecziguard and Yas antacid salt. The company started its expansion project in 1994 of setting up a new manufacturing plant in Pithampur Madhya Pradesh which was completed in 1995. During the financial year 1998-99, big expansions in the installed capacity and production base, and the introduction of products in the generic OTC and Ethical divisions were made. The exports boasted an increase of more than 100% and received orders worth Rs.700 lacs. It has been approved as a supplier to Central ESI Hospitals and registered for defence services that will augment the sales volume. Syncom Formulations India is continuously working towards growth and aims to significantly increase its product portfolio and customer base.

Revenue: ₹127.53Cr as on December 2024 (Q4 24)
Net Profit: ₹13.00Cr as on December 2024 (Q4 24)
Listing date: 18 Nov, 2022
Chairperson Name: Kedarmal Bankda
OrganisationSyncom Formulations (India) Ltd
HeadquartersIndore
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Syncom Formulations (India) Ltd

What is Syncom Formulations (India) Ltd price today?

Syncom Formulations (India) Ltd share price today stands at ₹17.14, Open: ₹17.78, Previous Close: ₹17.78, High: ₹17.8, Low: ₹16.9, 52 Week High: ₹27.9, 52 Week Low: ₹10.95.

How to Buy Syncom Formulations (India) Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Syncom Formulations (India) Ltd shares

What are today's traded volumes of Syncom Formulations (India) Ltd?

Today's traded volume of Syncom Formulations (India) Ltd(SYNCOMF) is 21.70L.

What is today's market capitalisation of Syncom Formulations (India) Ltd?

Today's market capitalisation of Syncom Formulations (India) Ltd(SYNCOMF) is ₹1611.16Cr.

What is the 52 Week High and Low Range of Syncom Formulations (India) Ltd?

Syncom Formulations (India) Ltd (SYNCOMF)
Price
52 Week High
₹27.9
52 Week Low
₹10.95

How much percentage Syncom Formulations (India) Ltd is down from its 52 Week High?

Syncom Formulations (India) Ltd (SYNCOMF) share price is ₹17.14. It is down -38.57% from its 52 Week High price of ₹27.9

How much percentage Syncom Formulations (India) Ltd is up from its 52 Week low?

Syncom Formulations (India) Ltd (SYNCOMF) share price is ₹17.14. It is up 56.53% from its 52 Week Low price of ₹10.95